|
Volumn 110, Issue 1 Pt 1, 2002, Pages
|
Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
DRUG DERIVATIVE;
EMOLLIENT AGENT;
NONSTEROID ANTIINFLAMMATORY AGENT;
PIMECROLIMUS;
TACROLIMUS;
ADOLESCENT;
ARTICLE;
ATOPIC DERMATITIS;
CHEMICALLY INDUCED DISORDER;
CHILD;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
EMULSION;
FEMALE;
FOLLOW UP;
HEADACHE;
HOSPITALIZATION;
HUMAN;
INFANT;
LIFE TABLE;
MALE;
MULTICENTER STUDY;
PATIENT;
PHARYNGITIS;
PRESCHOOL CHILD;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ADOLESCENT;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
CHILD;
CHILD, PRESCHOOL;
DERMATITIS, ATOPIC;
DOUBLE-BLIND METHOD;
EMOLLIENTS;
EMULSIONS;
FEMALE;
FOLLOW-UP STUDIES;
HEADACHE;
HUMANS;
INFANT;
LIFE TABLES;
MALE;
PATIENT DROPOUTS;
PHARYNGITIS;
SEVERITY OF ILLNESS INDEX;
TACROLIMUS;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
EID: 0036634394
PISSN: None
EISSN: 10984275
Source Type: Journal
DOI: 10.1542/peds.110.1.e2 Document Type: Article |
Times cited : (346)
|
References (0)
|